Benzinga.com

FDA Signs Off On Bayer's New Lung Cancer Drug — Early Results Look Promising

The Food and Drug Administration (FDA) on Wednesday granted accelerated approval to Bayer AG‘s (OTC: BAYRY) Hyrnuo (sevabertinib) for adults with a specific type of advanced lung cancer. The approval ...
Morningstar

Bayer Initiates Phase I Study Targeting GPC3 With Actinium-225 Radiopharmaceutical in Patients With Advanced Hepatocellular Carcinoma

Bayer announced today initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted alpha radiopharmaceutical being developed to treat tumors expressing Glypican-3 ...
SpaceNews

Tag: Bayer Advanced

The Brigham Young University student rocketeers blasted their way into history today, setting a new GUINNESS WORLD RECORDS title for Highest launch of an Alka-Rocket* in the 2018 Bayer Alka-Rocket ...
Barron's

Bayer AG

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science ...